Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:49 pm Purchase | 13G | KALA BIO, INC. KALA | ADAR1 Capital Management LLC | 480,431 9.990% | 480,431 (New Position) | View |
| 2024-11-14 4:48 pm Purchase | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 966,298 9.990% | 966,298 (New Position) | View |
| 2024-11-14 4:47 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Capital Management LLC | 3,684,708 8.510% | 3,684,708 (New Position) | View |
| 2024-11-14 4:47 pm Purchase | 13G | ZURA BIO LTD ZURA | ADAR1 Capital Management LLC | 3,332,835 5.100% | 3,332,835 (New Position) | View |
| 2024-11-14 4:46 pm Purchase | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | ADAR1 Capital Management LLC | 750,000 8.420% | 750,000 (New Position) | View |
| 2024-11-14 4:45 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 315,103 9.990% | 315,103 (New Position) | View |
| 2024-11-14 4:40 pm Purchase | 13G | GRACE THERAPEUTICS, INC GRCE | ADAR1 Capital Management LLC | 1,029,997 9.990% | 70,426 (+7.34%) | View |
| 2024-08-01 08:00 am Purchase | 13G | PIERIS PHARMACEUTICALS INC. PIRS | ADAR1 Capital Management LLC | 138,641 10.500% | 138,641 (New Position) | View |
| 2024-07-10 9:10 pm Purchase | 13G | GRACE THERAPEUTICS, INC GRCE | ADAR1 Capital Management LLC | 959,571 10.200% | 959,571 (New Position) | View |